The ABC19 test has been removed form the EUA list. This might explain why the SP for Abingdon has taken a nose dive. This won't affect Omega as we will be producing Antigen tests from various other companies including Mologic. We also have the Visitech Antibody test which we currently also sell with various other companies including Screen4.
sledgey - I wouldn't be in that at any time. Always dangerous to buy shares in a newly formed company. Anyone invested over there may have a longer wait to at least break even, but I'm sure Abingdon will bounce back.
Penance - That's what trading is about, it's all risk nothing is guaranteed. I've been in and out of ODX for over a year now and from what I've seen and know about the company, 66 is a bargain.
There is no dirty laundry. Mologic has already been given awarded a contract by America's National Instutute of Health. The contract is only worth $65M but it's a start. Question is how much will Omega manufacture.
The Placing Shares were supposed to have been admitted to the Market today but that didn't happen. They have up until the 30th April to admit the 56M shares. It will be interesting to see what the dilution does to the SP.
So we close the week higher than we started it, you wouldn't think so after that drop this week. But the stock has recovered well, hopefully the bounce up continues well into next week.